HSP90AA1 and cancer: Furthermore, levels of NANOG and HSP90A within the tumor correlated strongly with disease progression and survival in cancer patients, indicating that the expression status of HSP90A (either alone or in conjunction with NANOG) within tumor tissue may serve as an excellent prognostic marker.